Literature DB >> 2142113

Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression.

D W Burget1, S G Chiverton, R H Hunt.   

Abstract

The optimal degree and duration of suppression of gastric acidity required for the healing of peptic ulcers has never been established. Although very potent inhibitors of acid secretion are now available, the need for this degree of suppression has not been shown, and there is a possibility of adverse effects because of pronounced acid inhibition. Therefore, a model has been constructed that defines the relationship between duodenal ulcer healing and antisecretory therapy. Acid suppression data were obtained directly from investigators as raw data from 24-hour studies of acid secretion. Twenty-one experiments from seven investigators provided 490 24-hour studies using 19 different treatment regimens. Healing data were collected from a metaanalysis of published clinical trials of duodenal ulcer healing. A total of 144 published trials in 14,208 patients provided healing data at several endoscopic endpoints for the 19 drug regimens for which acidity data were provided. Weighted least-squares polynomial regression analysis was used to define those parameters of antisecretory therapy that contributed most to duodenal ulcer healing and to define the shape of the response surface. A highly significant correlation (r = 0.9814) was found between healing and the degree of acid suppression, the duration of acid suppression, and the length of therapy. The shape of the contour expression this relationship shows that healing increases as the duration of suppression increases and as gastric pH increases. However, suppression that increased pH beyond 3.0 was not found to increase ulcer healing further. It is concluded that a longer duration of antisecretory effect and/or a longer duration of therapy are of greater importance than potency for duodenal ulcer healing.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2142113     DOI: 10.1016/0016-5085(90)91015-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  75 in total

1.  Food but not a chemically defined diet interferes with maintenance of intragastric pH at a predefined level using continuous pH-stat-adjusted intravenous infusion of ranitidine in healthy volunteers.

Authors:  A B Thomson; P Kirdeikis; R Lastiwka; L Zuk; M Jen; M Elias; P Johnston
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

2.  Mealtime versus nighttime acid inhibition. A clinical pharmacological study with ranitidine.

Authors:  V Savarino; G S Mela; P Zentilin; S Vigneri; P Cutela; R Mele; F Di Mario
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

3.  New PC-based program to calculate gastric secretion and emptying using a marker dilution technique.

Authors:  A Dubois; M Mizrahi
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

4.  Early effects of oral administration of omeprazole and roxatidine on intragastric pH.

Authors:  Hiroshi Iida; Shingo Kato; Yusuke Sekino; Eiji Sakai; Takashi Uchiyama; Hiroki Endo; Kunihiro Hosono; Yasunari Sakamoto; Koji Fujita; Masato Yoneda; Tomoko Koide; Hirokazu Takahashi; Chikako Tokoro; Ayumu Goto; Yasunobu Abe; Noritoshi Kobayashi; Kensuke Kubota; Eiji Gotoh; Shin Maeda; Atsushi Nakajima; Masahiko Inamori
Journal:  J Zhejiang Univ Sci B       Date:  2012-01       Impact factor: 3.066

5.  Acid suppression.

Authors:  R H Hunt
Journal:  BMJ       Date:  1990-11-03

6.  Duodenal ulcer, gastric acid, and Helicobacter pylori.

Authors: 
Journal:  BMJ       Date:  1991-06-01

7.  U.S. experience with omeprazole in duodenal ulcer. Multicenter double-blind comparative study with ranitidine. The Omeprazole DU Comparative Study Group.

Authors:  J E Valenzuela; R G Berlin; W J Snape; T L Johnson; B I Hirschowitz; J Colon-Pagan; R S Morse; J Petrozza; G M Van Deventer; A Cagliola
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

Review 8.  What is potent acid inhibition, and how can it be achieved?

Authors:  Xavier Calvet; Fernando Gomollón
Journal:  Drugs       Date:  2005       Impact factor: 9.546

9.  Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z.

Authors:  R H Hunt; D Armstrong; M Yaghoobi; C James; Y Chen; J Leonard; J M Shin; E Lee; D Tang-Liu; G Sachs
Journal:  Aliment Pharmacol Ther       Date:  2008-04-25       Impact factor: 8.171

10.  Changes in nocturnal and peak acid outputs after duodenal ulcer healing with sucralfate or ranitidine.

Authors:  A F Kummer; D A Johnston; I N Marks; G O Young; N A Tigler-Wybrandi; S A Bridger
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.